Login / Signup

RAASI, NSAIDs, antidiabetics, and anticoagulants: More data needed to be labeled as harmful or neutral in SARS-CoV-2 infection.

Elisa GremeseStefano AliverniniGianfranco Ferraccioli
Published in: Proceedings of the National Academy of Sciences of the United States of America (2021)
Keyphrases
  • electronic health record
  • respiratory syndrome coronavirus
  • pet imaging
  • big data
  • anti inflammatory drugs
  • computed tomography
  • sars cov
  • coronavirus disease